Abstract
Study objectives
Neuronal intranuclear inclusion disease (NIID) is a rare progressive neurodegenerative disorder, with complex and diverse of clinical manifestations characterized by eosinophilic hyaline inclusions in neurons and somatic cells. Due to the improvement in diagnostic methods, NIID is being increasingly diagnosed.
Methods
Herein, we reported three NIID cases, which were diagnosed by skin biopsy and FMR1 gene, after DWI showed the characteristic corticomedullary junction hyperintensity. Then we reviewed all the published cases of NIID in PubMed, which were diagnosed by the same method.
Results
We discussed 15 NIID cases, including three cases diagnosed by us. The average age was 63.4 ± 14.0 years. The average time from onset of symptom to diagnosis was 5.4 ± 7.9 years. Nine cases had dementia or cognitive impairment. Three cases presented with encephalitis. Three cases showed bladder dysfunction and two cases only presented with dizziness and headache. Two cases showed acute neurological deficit mimicking stroke. All cases were diagnosed by skin biopsy, after DWI showed abnormal corticomedullary junction hyperintensity. Ten cases showed inclusions in sweat gland cells, and seven cases in adipocytes, sweat gland cells, and fibroblasts. EMG was performed in five cases, four of whom had abnormal results, showing simultaneous involvement of motor and sensory nerves.
Conclusions
The results indicated that inclusions were more easily detected in sweat gland cells in skin biopsy. The early stage of NIID could only characterized by autonomic nerve function involvement. Combined autonomic nerve dysfunction might be another relatively common manifestation in NIID.
Similar content being viewed by others
References
Motoki M, Nakajima H, Sato T, Tada M, Kakita A, Arawaka S (2018) Neuronal intranuclear inclusion disease showing intranuclear inclusions in renal biopsy 12 years earlier. Neurology 91:884–886
Paviour DC, Revesz T, Holton JL, Evans A, Olsson JE, Lees AJ (2005) Neuronal intranuclear inclusion disease: report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies. Mov Disord 20:1345–1349
Mori F, Miki Y, Tanji K, Ogura E, Yagihashi N, Jensen PH et al (2011) Incipient intranuclear inclusion body disease in a 78-year-old woman. Neuropathology 31:188–193
Lindenberg R, Rubinstein LJ, Herman MM, Haydon GB (1968) A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol 10:54–73
Tian Y, Wang JL, Huang W, Zeng S, Jiao B, Liu Z et al (2019) Expansion of human-specific GGC repeat in neuronal intranuclear inclusion disease-related disorders. Am J Hum Genet 105:166–176
Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K et al (2019) Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet 51:1215–1221
Deng JW, Gu ML, Miao Y, Yao S, Zhu M, Fang P et al (2019) Long-read sequencing identified repeat expansions in the 5′ UTR of the NOTCH2NLC gene from Chinese patients with neuronal intranuclear inclusion disease. J Med Genet 56:758–764
Sone J, Tanaka F, Koike H, Inukai A, Katsuno M, Yoshida M et al (2011) Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology 76:1372–1376
Yu WY, Xu ZY, Lee HY, Tokumaru A, Tan JMM, Ng A et al (2019) Identifying patients with neuronal intranuclear inclusion disease in Singapore using characteristic diffusion-weighted MR images. Neuroradiology 61:1281–1290
Omoto S, Hayashi T, Matsuno H, Higa H, Kameya S, Sengoku R et al (2018) Neuronal intranuclear hyaline inclusion disease presenting with childhood-onset night blindness associated with progressive retinal dystrophy. J Neurol Sci 388:84–86
Santoro MR, Bray SM, Warren ST (2012) Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol 7:219–245
Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A et al (2006) Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129:243–255
Chen LZ, Chen AS, Lei S, He L, Zhou MK (2019) Teaching NeuroImages: the zigzag edging sign of adult-onset neuronal intranuclear inclusion disease. Neurology 92:E2295–E2296
Morimoto S, Hatsuta H, Komiya T, Kanemaru K, Tokumaru AM, Murayama S (2017) Simultaneous skin-nerve-muscle biopsy and abnormal mitochondrial inclusions in intranuclear hyaline inclusion body disease. J Neurol Sci 372:447–449
Sone J, Kitagawa N, Sugawara E, Iguchi M, Nakamura R, Koike H et al (2014) Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatry 85:354–356
Fujita K, Osaki Y, Miyamoto R, Shimatani Y, Abe T, Sumikura H et al (2017) Neurologic attack and dynamic perfusion abnormality in neuronal intranuclear inclusion disease. Neurol-Clin Pract 7:E39–E42
Suthiphosuwan S, Sasikumar S, Munoz DG, Chan DK, Montanera WJ, Bharatha A (2019) MRI diagnosis of neuronal intranuclear inclusion disease leukoencephalopathy. Neurol-Clin Pract 9:497–499
Xiao F, Tian X, Wang XF (2018) Cerebral atrophy and leukoencephalopathy in a young man presenting with encephalitic episodes. JAMA Neurol 75:1563–1564
Nakamura M, Ueki S, Kubo M, Yagi H, Sasaki R, Okada Y et al (2018) Two cases of sporadic adult-onset neuronal intranuclear inclusion disease preceded by urinary disturbance for many years. J Neurol Sci 392:89–93
Guo J-J, Wang Z-Y, Wang M, Jiang Z-Z, Yu X-F (2020) Neuronal intranuclear inclusion disease mimicking acute cerebellitis: a case report. World J Clin Cases 8:6122–6129
Qin X, Chen H, Zhou C, Wang X, Gao J, Guo N et al (2021) Neuronal intranuclear inclusion disease: two case report and literature review. Neurol Sci 42:293–296
Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S et al (2016) Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain 139:3170–3186
Harigaya Y, Nakano Y, Hatsuta H, Sato M, Mizushima K, Murayama S (2016) Clinical features of adult-onset neuronal intranuclear inclusion disease. Eur J Neurol 23:346–346
Liu XY, Liu XH, Du YF, Lin YT, Li CX, Liu CC et al (2019) A case of recurrent vomiting: extending the spectrum of neuronal intranuclear inclusion disease. Neurol Sci 40:2661–2664
Munoz-Garcia D, Ludwin SK (1986) Adult-onset neuronal intranuclear hyaline inclusion disease. Neurology 36:785–790
Kulikova-Schupak R, Knupp KG, Pascual JM, Chin SS, Kairam R, Patterson MC (2004) Rectal biopsy in the diagnosis of neuronal intranuclear hyaline inclusion disease. J Child Neurol 19:59–62
Yokoi S, Yasui K, Hasegawa Y, Niwa K, Noguchi Y, Tsuzuki T et al (2016) Pathological background of subcortical hyperintensities on diffusion-weighted images in a case of neuronal intranuclear inclusion disease. Clin Neuropathol 35:375–380
Yamaguchi N, Mano T, Ohtomo R, Ishiura H, Almansour MA, Mori H et al (2018) An autopsy case of familial neuronal intranuclear inclusion disease with dementia and neuropathy. Intern Med 57:3459–3462
Michaud J, Gilbert JJ (1981) Multiple system atrophy with neuronal intranuclear hyaline inclusions. Report of a new case with light and electron microscopic studies. Acta Neuropathol 54:113–119
Mori F, Tanji K, Miki Y, Toyoshima Y, Sasaki H, Yoshida M et al (2018) Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease. Neurosci Lett 662:389–394
Pountney DL, Raftery MJ, Chegini F, Blumbergs PC, Gai WP (2008) NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture. Acta Neuropathol 116:603–614
Ishiura H, Shibata S, Yoshimura J, Suzuki Y, Qu W, Doi K et al (2019) Noncoding CGG repeat expansions in neuronal intranuclear inclusion dis ease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet 51:1222–1232
Sun QY, Xu Q, Tian Y, Hu ZM, Qin LX, Yang JX et al (2020) Expansion of GGC repeat in the human-specific NOTCH2NLC gene is associated with essential tremor. Brain 143:222–233
Funding
No funding was received for conducting this study.
Author information
Authors and Affiliations
Contributions
G-JZ, DW, Y-XZ, and H-FN acquired and analyzed the experiment data. G-JZ drafted the manuscript. Z-JZ and DW revised the manuscript and approved the final version to be published.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
This study was approved by the ethics committee of Affiliated Zhongda Hospital, Southeast University.
Consent to participate
Written informed consent was obtained from the parents.
Consent for publication
The participant has consented to the submission of the manuscript to the journal.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, GJ., Wu, D., Zhu, YX. et al. Clinicopathological features of neuronal intranuclear inclusion disease diagnosed by skin biopsy. Neurol Sci 43, 1809–1815 (2022). https://doi.org/10.1007/s10072-021-05526-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05526-2